Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 26, 2015 7:22 PM ET

Biotechnology

Company Overview of Carolus Therapeutics, Inc.

Company Overview

Carolus Therapeutics, Inc., a development-stage biopharmaceutical company, develops drugs for the treatment of acute and chronic inflammatory diseases in the United States. The company focuses on therapeutic strategies to noninvasively monitor and disrupt proinflammatory interactions of chemokines, and prevent or reverse inflammation associated with an array of human diseases, including atherosclerosis, rheumatoid arthritis, multiple sclerosis, sepsis, organ transplantation, and cancer. Carolus Therapeutics, Inc. was incorporated in 2007 and is based in San Diego, California.

5626 Oberlin Drive

Suite 100

San Diego, CA 92121

United States

Founded in 2007

Phone:

858-768-7823

Fax:

858-200-0821

Key Executives for Carolus Therapeutics, Inc.

Chief Executive Officer, President, and Director
Co-Founder and Chairman
Age: 52
Co-Founder and Member of the Scientific Advisory Board
Co-Founder and Member of the Scientific Advisory Board
Chief Financial Officer
Compensation as of Fiscal Year 2014.

Carolus Therapeutics, Inc. Key Developments

Carolus Therapeutics and The Alpha-1 Project Collaborate to Validate CT-2009 Target as Important in Human Disease

Carolus Therapeutics, Inc. and The Alpha-1 Project, Inc. announced that they are collaborating to characterize human biological samples for the presence of the novel target, RANTES:PF4 heterodimer (the heteromer), a soluble protein complex that is secreted by activated platelets and implicated in many inflammation-related diseases, including genetic emphysema and COPD (chronic obstructive pulmonary disease).

Similar Private Companies By Industry

Company Name Region
BioSamPle Solutions LLC United States
QIAGEN North American Holdings Inc. United States
Allos Therapeutics, Inc. United States
Genprex, Inc. United States
Azopax Therapeutics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Carolus Therapeutics, Inc., please visit www.carolustherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.